A novel high-throughput pepT1 transporter assay differentiates between substrates and antagonists

scientific article published in January 2004

A novel high-throughput pepT1 transporter assay differentiates between substrates and antagonists is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1021/MP034001K
P698PubMed publication ID15832502

P2093author name stringC David Weaver
Gordon L Amidon
Balvinder S Vig
Christopher P Landowski
Doris A Wall
Julita K Timoszyk
Ronald L Smith
Teresa N Faria
Terry R Stouch
P433issue1
P407language of work or nameEnglishQ1860
P304page(s)67-76
P577publication date2004-01-01
P1433published inMolecular PharmaceuticsQ3011140
P1476titleA novel high-throughput pepT1 transporter assay differentiates between substrates and antagonists
P478volume1

Reverse relations

cites work (P2860)
Q27666182Crystal structure of a prokaryotic homologue of the mammalian oligopeptide-proton symporters, PepT1 and PepT2
Q39884569Delta-aminolevulinic acid is a substrate for the amino acid transporter SLC36A1 (hPAT1).
Q80094731Design, synthesis, and evaluation of tripeptidic promoieties targeting the intestinal peptide transporter hPEPT1
Q33474995Discovery of ligands for the human intestinal Di-/Tripeptide transporter (hPEPT1) using a QSAR-assisted virtual screening strategy
Q42581818Enhancing the intestinal membrane permeability of zanamivir: a carrier mediated prodrug approach
Q46678390Floxuridine amino acid ester prodrugs: enhancing Caco-2 permeability and resistance to glycosidic bond metabolism
Q88453320Function, Regulation, and Pathophysiological Relevance of the POT Superfamily, Specifically PepT1 in Inflammatory Bowel Disease
Q42069147Functional implications and ubiquitin-dependent degradation of the peptide transporter Ptr2 in Saccharomyces cerevisiae
Q39665168Ibuprofen is a non-competitive inhibitor of the peptide transporter hPEPT1 (SLC15A1): possible interactions between hPEPT1 substrates and ibuprofen
Q43169439In vitro interactions between aged garlic extract and drugs used for the treatment of cardiovascular and diabetic patients
Q37139860Pharmaceutical and pharmacological importance of peptide transporters
Q36105344Role of the intestinal peptide transporter PEPT1 in oseltamivir absorption: in vitro and in vivo studies
Q38264736Strategic approaches to optimizing peptide ADME properties
Q27678780Structural basis for dynamic mechanism of proton-coupled symport by the peptide transporter POT
Q46839960Substrate specificity and mechanism of the intestinal clonidine uptake by Caco-2 cells
Q37515414Transport of drugs by proton-coupled peptide transporters: pearls and pitfalls

Search more.